vimarsana.com

SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today confirmed that its Allplex SARS-CoV-2 Master Assay is capable

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Kostenloser Wertpapierhandel ,Jong Yoon Chun ,World Health Organization ,Prnewswire Seegene Inc ,Seegene Founder ,Seegene ,Thigh ,Multiplex ,Essay ,Capable ,Detecting ,Micron ,Variant ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.